What are the treatment options for gout?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Gout Treatment Options

For acute gout flares, first-line treatment includes NSAIDs, low-dose colchicine (1.2 mg initially, followed by 0.6 mg after 1 hour), or corticosteroids, with treatment selection based on patient comorbidities and contraindications. 1

Acute Gout Management

First-Line Options

  • NSAIDs (naproxen, indomethacin)

    • Effective for acute flares
    • Avoid in patients with renal impairment, heart failure, peptic ulcer disease, or GI bleeding 1
    • Consider gastroprotection with PPI in high-risk patients
  • Colchicine

    • Low-dose regimen: 1.2 mg initially, followed by 0.6 mg after 1 hour
    • As effective as high-dose with fewer GI side effects
    • Dose adjustments required in renal impairment:
      • For severe impairment (CrCl <30 mL/min): treatment course should not be repeated more than once every two weeks 2
      • For dialysis patients: reduced to single dose of 0.6 mg, not repeated more than once every two weeks 2
    • Monitor for early signs of toxicity (gastrointestinal symptoms) 1
    • Avoid combining with NSAIDs due to synergistic GI toxicity 1
  • Corticosteroids

    • Oral: Prednisolone 30-35 mg daily for 3-5 days
    • Intra-articular injection for 1-2 affected joints
    • Methylprednisolone IV/IM at 0.5-2.0 mg/kg
    • Good option for patients with renal disease, heart failure, or cirrhosis 1
  • Synthetic ACTH

    • Subcutaneous administration at 25-40 UI initially 1

Long-Term Management

Urate-Lowering Therapy (ULT)

Indications for ULT:

  • Recurrent gout attacks (≥2 per year)
  • Presence of tophi
  • Joint damage
  • Chronic kidney disease or urolithiasis 1

Treatment Options:

  1. Allopurinol (First-line)

    • Initial dose: 100 mg daily (lower in renal insufficiency)
    • Titrate to achieve target serum urate <6 mg/dL 1
    • Dose should be tailored according to renal function
  2. Febuxostat (Alternative)

    • When allopurinol is not tolerated
    • Use with caution due to potential cardiovascular risks 1
  3. Uricosuric Agents

    • Probenecid, sulphinpyrazone
    • Contraindicated in urolithiasis
    • Benzbromarone can be used in mild to moderate renal insufficiency 1
  4. Pegloticase

    • Reserved for treatment failures
    • Strongly recommended for patients with frequent flares or nonresolving tophi despite other ULT 1

Prophylaxis When Starting ULT

  • Low-dose colchicine or NSAIDs for at least 8 weeks
  • Continue for 3-6 months after achieving target uric acid levels 1

Lifestyle Modifications

  • Dietary Restrictions:

    • Limit purine-rich foods (organ meats, shellfish)
    • Avoid alcohol, especially beer
    • Avoid beverages sweetened with high-fructose corn syrup 1
  • Dietary Recommendations:

    • Increase low-fat dairy products
    • Ensure adequate hydration (at least 2 liters daily)
    • Regular moderate physical activity 1

Special Considerations

Renal Impairment

  • Assess renal function before initiating therapy
  • Avoid NSAIDs and use colchicine with caution if eGFR <30 ml/min
  • Consider reduced doses of colchicine if eGFR 30-60 ml/min 1, 2

Hepatic Impairment

  • For acute flares: No dose adjustment needed for mild to moderate impairment
  • For severe impairment: Treatment course should not be repeated more than once every two weeks 2
  • For prophylaxis: Consider dose reduction in severe hepatic impairment 2

Pregnancy

  • Oral, intramuscular, or intra-articular glucocorticoids are recommended
  • Options include prednisone 30-35 mg daily for 3-5 days or intra-articular injections 1

Common Pitfalls to Avoid

  1. Failure to confirm diagnosis - Joint aspiration with synovial fluid analysis for monosodium urate crystals is the reference standard 1

  2. Inappropriate colchicine dosing - Using standard doses in renal impairment can lead to severe toxicity 1, 2

  3. Missing drug interactions - Check for P-glycoprotein/CYP3A4 inhibitors and concurrent statin therapy 1

  4. Inadequate prophylaxis - Not providing prophylaxis when initiating ULT can trigger flares 1

  5. Insufficient ULT dose titration - Failure to titrate allopurinol to achieve target serum urate levels 1

References

Guideline

Acute Gout Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.